Obesity differentially affects serum levels of androstenedione and testosterone in polycystic ovary syndrome

Fertil Steril. 2008 Dec;90(6):2310-7. doi: 10.1016/j.fertnstert.2007.09.016. Epub 2007 Dec 27.

Abstract

Objective: To assess androstenedione (A) and T levels in obese and nonobese patients with polycystic ovary syndrome (PCOS) after GnRH and oral glucose tolerance tests (OGTT).

Design: Cross sectional study.

Setting: Clinical research center.

Patient(s): Thirty patients with PCOS, of whom 15 were obese and 15 were nonobese, and 7 women without PCOS were included in the study.

Intervention(s): The GnRH test and OGTT were performed in all subjects.

Main outcome measure(s): Basal and stimulated levels of LH, FSH, insulin, A, and total T were measured. Areas under the curve (AUCs) and AUC change after stimulation for these hormones were calculated.

Result(s): The basal T levels were significantly higher in obese than in nonobese patients with PCOS. In contrast, the basal levels of A were similar in obese and nonobese patients with PCOS. The T(AUC) after GnRH was significantly greater in obese than in nonobese patients with PCOS but was not significantly different after OGTT. The A(AUC) after GnRH and OGTT was significantly greater in nonobese than in obese patients with PCOS. However, there were no significant differences in T(AUC) and A(AUC) changes after GnRH and OGTT.

Conclusion(s): A different pattern in the levels of T and A with respect to obesity in PCOS was observed, suggesting a shift in ovarian enzymatic function.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Androstenedione / blood*
  • Biomarkers / blood
  • Cross-Sectional Studies
  • Female
  • Follicle Stimulating Hormone, Human / blood
  • Glucose Tolerance Test
  • Gonadotropin-Releasing Hormone / administration & dosage
  • Humans
  • Insulin / blood
  • Luteinizing Hormone / blood
  • Obesity / blood*
  • Obesity / complications
  • Ovarian Function Tests
  • Polycystic Ovary Syndrome / blood*
  • Polycystic Ovary Syndrome / complications
  • Testosterone / blood*
  • Time Factors
  • Young Adult

Substances

  • Biomarkers
  • Follicle Stimulating Hormone, Human
  • Insulin
  • Gonadotropin-Releasing Hormone
  • Testosterone
  • Androstenedione
  • Luteinizing Hormone